For lung cancer cells, SHK has been specifically shown to cause death of these cells via dysregulation of the ubiquitin-proteasome pathway, activation of caspases, and inhibition of cyclooxygenase-2 [28, 29, 32, 47, 48]. The gene discussed is SHPK; the disease is lung carcinoma.